Cancer Treatment Patent - Three Inventors, Apr 23 2026
Summary
USPTO published patent application US20260108512A1 for cancer treatment compounds and pharmaceutical compositions filed by inventors Yingzhi BI, Kenneth G. CARSON, and Geraldine Cirillo HARRIMAN. The application, assigned CPC classifications A61K 31/501, A61K 31/437, A61P 35/00, and C07D 471/04, was filed on April 7, 2025 and published on April 23, 2026. The abstract discloses compounds designed to treat or lessen the severity of cancer along with methods of making and using the compositions.
“The present disclose includes, among other things, compounds that treat or lessen the severity of cancer, pharmaceutical compositions and methods of making and using the same.”
About this source
GovPing monitors USPTO Patent Applications - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 233 changes logged to date.
What changed
USPTO published patent application US20260108512A1 for compounds, compositions and methods of treating cancer. The application names three inventors: Yingzhi BI, Kenneth G. CARSON, and Geraldine Cirillo HARRIMAN. The abstract describes compounds designed to treat or lessen the severity of cancer, pharmaceutical compositions, and methods of making and using the same.
Affected parties in the pharmaceutical and biotechnology sectors should note this application for potential freedom-to-operate considerations, licensing opportunities, or competitive landscape assessment. Patent applications do not create immediate legal obligations but establish priority dates for the claimed inventions.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS
Application US20260108512A1 Kind: A1 Apr 23, 2026
Inventors
Yingzhi BI, Kenneth G. CARSON, Geraldine Cirillo HARRIMAN
Abstract
The present disclose includes, among other things, compounds that treat or lessen the severity of cancer, pharmaceutical compositions and methods of making and using the same.
CPC Classifications
A61K 31/501 A61K 31/437 A61P 35/00 C07D 471/04
Filing Date
2025-04-07
Application No.
19172091
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.